Adalimumab vs Pembrolizumab

## Adalimumab vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Pembrolizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Adalimumab — Antibody; Pembrolizumab — Antibody.